bioAffinity Technologies (BIAF) Competitors $1.23 -0.05 (-3.54%) (As of 02:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BIAF vs. YYGH, TETE, MOBQ, PSQH, VCSA, FORA, JUNE, BGSF, HGBL, and LUNAShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include YY Group (YYGH), Technology & Telecommunication Acquisition (TETE), Mobiquity Technologies (MOBQ), PSQ (PSQH), Vacasa (VCSA), Forian (FORA), Junee (JUNE), BGSF (BGSF), Heritage Global (HGBL), and Luna Innovations (LUNA). These companies are all part of the "business services" industry. bioAffinity Technologies vs. YY Group Technology & Telecommunication Acquisition Mobiquity Technologies PSQ Vacasa Forian Junee BGSF Heritage Global Luna Innovations bioAffinity Technologies (NASDAQ:BIAF) and YY Group (NASDAQ:YYGH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, community ranking, risk, institutional ownership and dividends. Does the MarketBeat Community favor BIAF or YYGH? bioAffinity Technologies received 1 more outperform votes than YY Group when rated by MarketBeat users. CompanyUnderperformOutperformbioAffinity TechnologiesOutperform Votes1100.00% Underperform VotesNo VotesYY GroupN/AN/A Is BIAF or YYGH more profitable? YY Group has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -91.22%. YY Group's return on equity of 0.00% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-91.22% -205.09% -115.95% YY Group N/A N/A N/A Which has better earnings and valuation, BIAF or YYGH? YY Group has higher revenue and earnings than bioAffinity Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$2.53M7.55-$7.94M-$0.82-1.49YY Group$31.77M2.35$850KN/AN/A Do institutionals & insiders hold more shares of BIAF or YYGH? 1.6% of bioAffinity Technologies shares are owned by institutional investors. 40.0% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer BIAF or YYGH? bioAffinity Technologies presently has a consensus price target of $6.00, suggesting a potential upside of 389.80%. Given bioAffinity Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe bioAffinity Technologies is more favorable than YY Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00YY Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer BIAF or YYGH? In the previous week, YY Group had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 4 mentions for YY Group and 3 mentions for bioAffinity Technologies. YY Group's average media sentiment score of 1.21 beat bioAffinity Technologies' score of -0.66 indicating that YY Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment bioAffinity Technologies 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative YY Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarybioAffinity Technologies and YY Group tied by winning 7 of the 14 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.10M$4.24B$5.10B$8.84BDividend YieldN/A1.65%5.04%4.07%P/E Ratio-1.4939.0995.6214.26Price / Sales7.5555.331,217.1987.73Price / CashN/A23.4239.5936.27Price / Book6.133.376.946.36Net Income-$7.94M$139.66M$118.89M$225.56M7 Day Performance-7.89%-1.85%-1.33%-0.10%1 Month Performance-14.93%14.12%-3.17%2.02%1 Year Performance-13.12%34.22%32.49%27.87% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies2.4464 of 5 stars$1.23-3.5%$6.00+389.8%-11.8%$19.10M$2.53M-1.4910Gap UpYYGHYY GroupN/A$1.89-0.5%N/AN/A$74.50M$31.77M0.00N/ANews CoveragePositive NewsTETETechnology & Telecommunication AcquisitionN/A$12.21+0.4%N/A+6.3%$73.02MN/A0.002Gap DownHigh Trading VolumeMOBQMobiquity TechnologiesN/A$4.16+10.6%N/A+743.0%$71.22M$860,000.000.0012PSQHPSQ3.3895 of 5 stars$2.20flat$3.50+59.1%-58.9%$69.06M$5.69M0.0045Analyst RevisionVCSAVacasa2.1124 of 5 stars$2.93+7.7%$6.08+107.6%-66.2%$66.72M$1.12B-0.336,400FORAForian1.6681 of 5 stars$2.10+2.4%$5.00+138.1%-17.7%$65.13M$19.71M-22.7836JUNEJuneeN/A$4.92-2.6%N/AN/A$63.86MN/A0.00N/AGap DownBGSFBGSF1.4232 of 5 stars$5.70+1.6%N/A-42.3%$62.81M$313.17M-56.09400HGBLHeritage Global1.7649 of 5 stars$1.62-0.6%N/A-44.0%$60.49M$60.54M5.8282LUNALuna Innovations2.2248 of 5 stars$1.65+1.2%$8.00+384.8%-71.9%$56.03M$109.50M0.00337 Related Companies and Tools Related Companies YY Group Competitors Technology & Telecommunication Acquisition Competitors Mobiquity Technologies Competitors PSQ Competitors Vacasa Competitors Forian Competitors Junee Competitors BGSF Competitors Heritage Global Competitors Luna Innovations Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BIAF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIAF Stock Alerts